PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
111.14%
Revenue growth similar to TLRY's 111.14%. Walter Schloss would see if both companies share industry tailwinds.
91.08%
Gross profit growth similar to TLRY's 91.08%. Walter Schloss would assume both firms track common industry trends.
10.33%
EBIT growth similar to TLRY's 10.33%. Walter Schloss might infer both firms share similar operational efficiencies.
10.33%
Operating income growth similar to TLRY's 10.33%. Walter Schloss would assume both share comparable operational structures.
10.46%
Net income growth comparable to TLRY's 10.46%. Walter Schloss might see both following similar market or cost trajectories.
10.98%
EPS growth similar to TLRY's 10.98%. Walter Schloss would assume both have parallel share structures and profit trends.
10.98%
Similar diluted EPS growth to TLRY's 10.98%. Walter Schloss might see standard sector or cyclical influences on both firms.
-1.98%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
0.00%
Diluted share count expanding well above TLRY's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
48.20%
Similar OCF growth to TLRY's 48.20%. Walter Schloss would assume comparable operations or industry factors.
11.57%
FCF growth similar to TLRY's 11.57%. Walter Schloss would attribute it to parallel capital spending and operational models.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-109.58%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-109.58%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-888.70%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-9.81%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-9.81%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-28.19%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
19.21%
10Y equity/share CAGR in line with TLRY's 19.21%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
19.21%
5Y equity/share CAGR is in line with TLRY's 19.21%. Walter Schloss would see parallel mid-term profitability and retention policies.
135.88%
3Y equity/share CAGR similar to TLRY's 135.88%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.20%
AR growth well above TLRY's 24.20%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.65%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.88%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-0.13%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
No Data
No Data available this quarter, please select a different quarter.
-37.31%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
53.56%
SG&A growth well above TLRY's 53.56%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.